Lokelma

Active Ingredient(s): Sodium Zirconium Cyclosilicate
FDA Approved: * May 18, 2018
Pharm Company: * ASTRAZENECA PHARMS
Category: Potassium Levels

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lokelma Overview

Sodium zirconium cyclosilicate (ZS-9) is a selective oral sorbent that traps potassium ions throughout the gastrointestinal tract. It is being developed by ZS Pharma and AstraZeneca for the treatment of hyperkalemia (elevated serum potassium levels).[1] Contents 1 Background 2 Mechanism of action 3 Clinical studies 4 Regulatory 5 See also 6 References Background Main article: Hyperkalemia Hyperkalemia occurs in 3 to 10% of hospitalized patients[2] but ...

Read more Lokelma Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Sodium_zirconium_cyclosilicate

Recent Lokelma Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Sodium Zirconium Cyclosilicate
  • For Suspension: 10gm/packet, 5gm/packet
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lokelma: (2 results)

Sorted by National Drug Code
  • 0310-1105 Lokelma 5 g/5g Oral Powder, for Suspension by Astrazeneca Pharmaceuticals Lp
  • 0310-1110 Lokelma 10 g/10g Oral Powder, for Suspension by Astrazeneca Pharmaceuticals Lp

Other drugs which contain Sodium Zirconium Cyclosilicate or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 November 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 501 S. Cherry St, Suite 1100, Denver, CO, 80246, USA